首页 > 最新文献

中国修复重建外科杂志最新文献

英文 中文
[Research progress in repair of post-epicanthoplasty deformity]. [上眦成形术后畸形修复的研究进展]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202509071
Boyang Ren, Wen Chen

Objective: To provide a comprehensive review of the surgical methods for repairing post-epicanthoplasty deformity, aiming to offer a reference for clinical decision-making in selecting appropriate techniques.

Methods: Relevant research literature concerning the repair of post-epicanthoplasty deformities was extensively reviewed. The background, clinical applications, and current challenges of these reconstructive procedures were summarized and analyzed.

Results: Post-epicanthoplasty deformities are not uncommon, and with evolving aesthetic standards, the demand for medial canthal reconstruction is increasing. The primary surgical techniques reported in the literature include the V-Y advancement flap, the reverse skin-redraping method, and the reverse Z-plasty. In recent years, the application of orbicularis oculi myocutaneous flaps has become more prevalent. While most of these procedures yield satisfactory outcomes, they still face certain limitations, particularly in addressing challenges related to scar management, individual patient variations, and the precise control of medial canthal morphology.

Conclusion: When clinically addressing post-epicanthoplasty deformities, surgeons must select the most suitable surgical method based on a comprehensive assessment of the patient's specific condition and various contributing factors. An individualized approach is crucial to achieving the optimal aesthetic and functional outcomes.

目的:综述修复上眦赘肉成形术后畸形的手术方法,为临床选择合适的手术方法提供参考。方法:广泛查阅有关外皮成形术后畸形修复的相关研究文献。对这些重建方法的背景、临床应用和当前面临的挑战进行了总结和分析。结果:上眦成形术后的畸形并不少见,随着审美标准的发展,对内眦重建的需求也在增加。文献中报道的主要手术技术包括V-Y推进皮瓣、反向皮肤重铺法和反向z形成形术。近年来,眼轮匝肌肌皮瓣的应用越来越普遍。虽然大多数这些手术产生了令人满意的结果,但它们仍然面临一定的局限性,特别是在解决与疤痕管理、个体患者差异和内侧眦形态精确控制相关的挑战方面。结论:在临床上处理表皮成形术后畸形时,外科医生必须综合评估患者的具体情况和各种影响因素,选择最合适的手术方法。个性化的方法对于实现最佳的美学和功能效果至关重要。
{"title":"[Research progress in repair of post-epicanthoplasty deformity].","authors":"Boyang Ren, Wen Chen","doi":"10.7507/1002-1892.202509071","DOIUrl":"10.7507/1002-1892.202509071","url":null,"abstract":"<p><strong>Objective: </strong>To provide a comprehensive review of the surgical methods for repairing post-epicanthoplasty deformity, aiming to offer a reference for clinical decision-making in selecting appropriate techniques.</p><p><strong>Methods: </strong>Relevant research literature concerning the repair of post-epicanthoplasty deformities was extensively reviewed. The background, clinical applications, and current challenges of these reconstructive procedures were summarized and analyzed.</p><p><strong>Results: </strong>Post-epicanthoplasty deformities are not uncommon, and with evolving aesthetic standards, the demand for medial canthal reconstruction is increasing. The primary surgical techniques reported in the literature include the V-Y advancement flap, the reverse skin-redraping method, and the reverse Z-plasty. In recent years, the application of orbicularis oculi myocutaneous flaps has become more prevalent. While most of these procedures yield satisfactory outcomes, they still face certain limitations, particularly in addressing challenges related to scar management, individual patient variations, and the precise control of medial canthal morphology.</p><p><strong>Conclusion: </strong>When clinically addressing post-epicanthoplasty deformities, surgeons must select the most suitable surgical method based on a comprehensive assessment of the patient's specific condition and various contributing factors. An individualized approach is crucial to achieving the optimal aesthetic and functional outcomes.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"364-368"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991881/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of disease burden of fall-related fractures among elderly Chinese from 1990 to 2023]. [1990 - 2023年中国老年人跌倒骨折疾病负担分析]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601056
Yating Zhou, Jian Zhong, Jie Liao, Shaokun Yang, Qiongyao Wu, Juying Zhang

Objective: To analyze the trends in the disease burden of fall-related fractures among elderly Chinese from 1990 to 2023, and to examine the disparities by age, gender, and fracture site, in order to inform the development of targeted strategies for the prevention of such fractures.

Methods: Data on the incidence, prevalence, and years lived with disability (YLDs) of fall-related fractures among elderly Chinese from 1990 and 2023 was sourced from the 2023 Global Burden of Disease (GBD) study. The disease burden across age groups, genders, and fracture sites was assessed. Furthermore, temporal trends by these strata were analyzed using Joinpoint 5.4.0.0 software.

Results: From 1990 to 2023, the average annual percent changes in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized years of life lost rate (ASYR) for fall-related fractures among elderly Chinese were 1.81%, 1.03%, and 0.83%, respectively. In China, the disease burden of fall-related fractures among the elderly increased with advancing age, and the rate of this increase accelerated in older age groups. Females had higher values than males in terms of ASIR, the rates of increase for all burden measures were greater in males. Fall-related fractures among the elderly Chinese can be classified into 12 sites, among which hip fracture had the highest ASIR, with values of 538.15 and 963.57 per 100 000 in 1990 and 2023, respectively. Fractures of the patella, tibia, fibula, or ankle had the highest ASPR and ASYR. Their ASPR were14 836.73 and 19 727.74 per 100 000 in 1990 and 2023, respectively, and ASYR were 740.84 and 989.54 per 100 000, respectively.

Conclusion: The increasing and heterogeneous burden of fall-related fractures among elderly Chinese calls for targeted management strategies, in addition to enhanced osteoporosis prevention, that address the distinct risks by gender, age, and fracture site.

目的:分析1990 - 2023年中国老年人跌倒相关骨折疾病负担的变化趋势,并分析年龄、性别和骨折部位的差异,为制定有针对性的预防策略提供依据。方法:1990年至2023年中国老年人跌倒相关骨折的发生率、患病率和残疾生存年限(YLDs)数据来源于2023年全球疾病负担(GBD)研究。评估了不同年龄组、性别和骨折部位的疾病负担。利用Joinpoint 5.4.0.0软件分析各地层的时间变化趋势。结果:从1990年到2023年,中国老年人跌倒相关骨折的年龄标准化发生率(ASIR)、年龄标准化患病率(ASPR)和年龄标准化生活年损失率(ASYR)的年平均变化百分比分别为1.81%、1.03%和0.83%。在中国,老年人跌倒相关骨折的疾病负担随着年龄的增长而增加,并且在老年群体中增加的速度加快。在ASIR方面,女性的数值高于男性,所有负担测量的增长率在男性中都更高。中国老年人跌倒相关骨折可分为12个部位,其中髋部骨折的ASIR最高,1990年为538.15 / 10万,2023年为963.57 / 10万。髌骨、胫骨、腓骨或踝关节骨折的ASPR和ASYR最高。1990年和2023年的ASPR分别为14 836.73和19 727.74 / 10万,ASYR分别为740.84和989.54 / 10万。结论:中国老年人跌倒相关骨折负担的增加和异质性要求有针对性的管理策略,除了加强骨质疏松症预防外,还需要解决性别、年龄和骨折部位的不同风险。
{"title":"[Analysis of disease burden of fall-related fractures among elderly Chinese from 1990 to 2023].","authors":"Yating Zhou, Jian Zhong, Jie Liao, Shaokun Yang, Qiongyao Wu, Juying Zhang","doi":"10.7507/1002-1892.202601056","DOIUrl":"10.7507/1002-1892.202601056","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the trends in the disease burden of fall-related fractures among elderly Chinese from 1990 to 2023, and to examine the disparities by age, gender, and fracture site, in order to inform the development of targeted strategies for the prevention of such fractures.</p><p><strong>Methods: </strong>Data on the incidence, prevalence, and years lived with disability (YLDs) of fall-related fractures among elderly Chinese from 1990 and 2023 was sourced from the 2023 Global Burden of Disease (GBD) study. The disease burden across age groups, genders, and fracture sites was assessed. Furthermore, temporal trends by these strata were analyzed using Joinpoint 5.4.0.0 software.</p><p><strong>Results: </strong>From 1990 to 2023, the average annual percent changes in the age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized years of life lost rate (ASYR) for fall-related fractures among elderly Chinese were 1.81%, 1.03%, and 0.83%, respectively. In China, the disease burden of fall-related fractures among the elderly increased with advancing age, and the rate of this increase accelerated in older age groups. Females had higher values than males in terms of ASIR, the rates of increase for all burden measures were greater in males. Fall-related fractures among the elderly Chinese can be classified into 12 sites, among which hip fracture had the highest ASIR, with values of 538.15 and 963.57 per 100 000 in 1990 and 2023, respectively. Fractures of the patella, tibia, fibula, or ankle had the highest ASPR and ASYR. Their ASPR were14 836.73 and 19 727.74 per 100 000 in 1990 and 2023, respectively, and ASYR were 740.84 and 989.54 per 100 000, respectively.</p><p><strong>Conclusion: </strong>The increasing and heterogeneous burden of fall-related fractures among elderly Chinese calls for targeted management strategies, in addition to enhanced osteoporosis prevention, that address the distinct risks by gender, age, and fracture site.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"397-404"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991878/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of Kartogenin in cartilage tissue engineering]. Kartogenin在软骨组织工程中的应用
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202510025
Jinhang Jiang, Shujiang Zhang, Weijie Lu

Objective: To review the research progress and application prospects of Kartogenin (KGN) in cartilage repair and tissue engineering.

Methods: Through a literature review, the mechanisms of KGN in cartilage repair, biomaterial composite strategies, and the resulting repair effectivenes were sorted out.

Results: KGN regulates multiple signaling pathways to induce mesenchymal stem cells differentiation into chondrocytes, maintain chondrocyte phenotypes, inhibit chondrocyte senescence, and promote the secretion of extracellular matrix. KGN also forms high-efficiency scaffolds with various materials, suitable for tissue engineering scaffolds of different anatomical sites and defect types, and exhibits significant cartilage regenerative effectiveness in vitro and small animal models.

Conclusion: Overall, KGN shows great application potential in cartilage tissue engineering. However, clinical translation still faces many challenges, which represents a key direction for future research.

目的:综述Kartogenin (KGN)在软骨修复和组织工程中的研究进展及应用前景。方法:通过文献综述,梳理KGN在软骨修复中的作用机制、生物材料复合策略及修复效果。结果:KGN调节多种信号通路,诱导间充质干细胞向软骨细胞分化,维持软骨细胞表型,抑制软骨细胞衰老,促进细胞外基质分泌。KGN还可以多种材料形成高效支架,适用于不同解剖部位和缺陷类型的组织工程支架,并在体外和小动物模型中显示出显著的软骨再生效果。结论:总的来说,KGN在软骨组织工程中具有很大的应用潜力。然而,临床翻译仍然面临许多挑战,这是未来研究的一个关键方向。
{"title":"[Application of Kartogenin in cartilage tissue engineering].","authors":"Jinhang Jiang, Shujiang Zhang, Weijie Lu","doi":"10.7507/1002-1892.202510025","DOIUrl":"10.7507/1002-1892.202510025","url":null,"abstract":"<p><strong>Objective: </strong>To review the research progress and application prospects of Kartogenin (KGN) in cartilage repair and tissue engineering.</p><p><strong>Methods: </strong>Through a literature review, the mechanisms of KGN in cartilage repair, biomaterial composite strategies, and the resulting repair effectivenes were sorted out.</p><p><strong>Results: </strong>KGN regulates multiple signaling pathways to induce mesenchymal stem cells differentiation into chondrocytes, maintain chondrocyte phenotypes, inhibit chondrocyte senescence, and promote the secretion of extracellular matrix. KGN also forms high-efficiency scaffolds with various materials, suitable for tissue engineering scaffolds of different anatomical sites and defect types, and exhibits significant cartilage regenerative effectiveness <i>in vitro</i> and small animal models.</p><p><strong>Conclusion: </strong>Overall, KGN shows great application potential in cartilage tissue engineering. However, clinical translation still faces many challenges, which represents a key direction for future research.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"502-510"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role and mechanism of chemokine network in promoting osteoarthritis progression by regulating synovial macrophage heterogeneity]. 趋化因子网络通过调节滑膜巨噬细胞异质性促进骨关节炎进展的作用和机制。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601130
Yuxuan Lin, Limin Wu, Quan Chen, Bin Shen

Objective: To review the role of chemokine networks in regulating synovial macrophage heterogeneity during osteoarthritis (OA) pathogenesis.

Methods: A review of recent literature on the developmental origins of OA synovial macrophages, single-cell transcriptomic characteristics, and chemokine signaling pathways was conducted to systematically summarize the functional phenotypes, immunometabolic mechanisms, and regulatory roles of synovial macrophages in OA.

Results: OA has been established as a low-grade, chronic inflammatory disease affecting the entire joint. Single-cell and spatial transcriptomic studies have confirmed that synovial macrophages are not a single population but rather a dynamic continuum of different functional states, including steady-state barrier-like, inflammatory amplification, fibrosis-related, and lipid-enriched phenotypes. Chemokine networks play a dual crucial role in this process: on one hand, chemokine gradients guide the migration of peripheral monocytes to the synovium and influence their differentiation; on the other hand, synovial macrophages in different states secrete chemokines, mediating transcellular communication between the synovium, subchondral bone, and peripheral nerves. This process reshapes the microenvironment and amplifies local inflammation and pain signals. Current therapeutic strategies targeting macrophage metabolic reprogramming and chemokine axis blockade show potential clinical applications.

Conclusion: Re-examining the interaction between synovial macrophages and microenvironment and constructing an integrated perspective of "lineage-state-chemokine network" will help to understand the pathological progression mechanism of OA. In the future, it is expected to provide a theoretical framework and intervention targets for the precise immune regulation of OA and the development of new targeted drugs by accurately analyzing the spatiotemporal evolution of macrophage subsets and their interaction with chemokines.

目的:探讨趋化因子网络在骨关节炎发病过程中调控滑膜巨噬细胞异质性中的作用。方法:通过对OA滑膜巨噬细胞的发育起源、单细胞转录组学特征、趋化因子信号通路等方面的文献综述,系统总结滑膜巨噬细胞在OA中的功能表型、免疫代谢机制和调控作用。结果:骨性关节炎是一种影响整个关节的低度慢性炎症性疾病。单细胞和空间转录组学研究证实,滑膜巨噬细胞不是一个单一的群体,而是不同功能状态的动态连续体,包括稳态屏障样、炎症扩增、纤维化相关和脂质富集表型。趋化因子网络在这一过程中发挥着双重关键作用:一方面,趋化因子梯度引导外周单核细胞向滑膜迁移并影响其分化;另一方面,不同状态的滑膜巨噬细胞分泌趋化因子,介导滑膜、软骨下骨和周围神经之间的跨细胞通讯。这个过程重塑了微环境,放大了局部炎症和疼痛信号。目前针对巨噬细胞代谢重编程和趋化因子轴阻断的治疗策略显示出潜在的临床应用前景。结论:重新审视滑膜巨噬细胞与微环境的相互作用,构建“谱系-状态-趋化因子网络”的综合视角,有助于理解骨性关节炎的病理进展机制。未来,通过准确分析巨噬细胞亚群的时空演化及其与趋化因子的相互作用,有望为OA的精准免疫调控和新型靶向药物的开发提供理论框架和干预靶点。
{"title":"[The role and mechanism of chemokine network in promoting osteoarthritis progression by regulating synovial macrophage heterogeneity].","authors":"Yuxuan Lin, Limin Wu, Quan Chen, Bin Shen","doi":"10.7507/1002-1892.202601130","DOIUrl":"10.7507/1002-1892.202601130","url":null,"abstract":"<p><strong>Objective: </strong>To review the role of chemokine networks in regulating synovial macrophage heterogeneity during osteoarthritis (OA) pathogenesis.</p><p><strong>Methods: </strong>A review of recent literature on the developmental origins of OA synovial macrophages, single-cell transcriptomic characteristics, and chemokine signaling pathways was conducted to systematically summarize the functional phenotypes, immunometabolic mechanisms, and regulatory roles of synovial macrophages in OA.</p><p><strong>Results: </strong>OA has been established as a low-grade, chronic inflammatory disease affecting the entire joint. Single-cell and spatial transcriptomic studies have confirmed that synovial macrophages are not a single population but rather a dynamic continuum of different functional states, including steady-state barrier-like, inflammatory amplification, fibrosis-related, and lipid-enriched phenotypes. Chemokine networks play a dual crucial role in this process: on one hand, chemokine gradients guide the migration of peripheral monocytes to the synovium and influence their differentiation; on the other hand, synovial macrophages in different states secrete chemokines, mediating transcellular communication between the synovium, subchondral bone, and peripheral nerves. This process reshapes the microenvironment and amplifies local inflammation and pain signals. Current therapeutic strategies targeting macrophage metabolic reprogramming and chemokine axis blockade show potential clinical applications.</p><p><strong>Conclusion: </strong>Re-examining the interaction between synovial macrophages and microenvironment and constructing an integrated perspective of \"lineage-state-chemokine network\" will help to understand the pathological progression mechanism of OA. In the future, it is expected to provide a theoretical framework and intervention targets for the precise immune regulation of OA and the development of new targeted drugs by accurately analyzing the spatiotemporal evolution of macrophage subsets and their interaction with chemokines.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"493-501"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of disease burden, attributable risk factors of low back pain in China from 1990 to 2023 and prediction for 2030]. [1990 - 2023年中国腰痛疾病负担、归因危险因素分析及2030年预测]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601044
Jun Wei, Rundong Chai, Beier Luo, Guanyi Wang, Tianhao Yang, Xin Wang, Yiwen Yan, Ming Yan, Zhengxu Ye, Jinghui Huang, Bo Gao, Zhuojing Luo

Objective: To analyze the changing trends and attributable risk factors of low back pain disease burden in Chinese population from 1990 to 2023, and to predict the related disease burden of low back pain in 2030.

Methods: Based on the 2023 Global Burden of Disease (GBD) study database, the incidence, prevalence, years lived with disability (YLDs), and characteristics and trends of risk factors among Chinese individuals with low back pain from 1990 to 2023 were analyzed, the age and gender differences in disease burden were assessed, and the disease burden in 2030 was jointly predicted by autoregressive integrated moving average model and age-period-cohort model.

Results: From 1990 to 2023, the number of incident cases, the number of prevalent cases, and YLDs in Chinese low back pain population showed an upward trend, from 29.989 1 million cases, 68.636 3 million cases, and 7.732 4 million person-years to 41.383 6 million cases, 95.324 0 million cases, and 10.635 9 million person-years, respectively. The incidence rate, prevalence rate, and YLDs rate increased from 2 543.31 per 100 000, 5 820.89 per 100 000, and 655.77 per 100 000 to 2 892.65 per 100 000, 6 663.01 per 100 000, and 743.43 per 100 000 respectively. However, the age-standardized incidence rate, age-standardized prevalence rate, and age-standardized YLDs rate showed a downward trend, from 2 859.73 per 100 000, 6 636.60 per 100 000, and 740.83 per 100 000 to 2 164.80 per 100 000, 4 929.78 per 100 000, and 551.92 per 100 000, respectively. The burden of low back pain in women was significantly higher than that in men and increased with age (peak at 50 to 59 years old). Attribution analysis showed that smoking, occupational factors, and high body mass index (BMI) were the main factors leading to the increase of YLDs, and there was a gender difference. The tow model showed that the age-standardized incidence rate, the age-standardized prevalence rate, and the age-standardized YLDs rate for low back pain would decrease year by year from 2023 to 2030.

Conclusion: The disease burden of low back pain in China shows that from 1990 to 2023, the burden of low back pain in the Chinese population has been increasing year by year. Smoking, occupational factors, and high BMI are the main risk factors. Interventions targeting these controllable risk factors are crucial for reducing the disease burden. It is expected that by 2030, the disease burden of low back pain is expected to decrease, although the absolute burden will remain high. Greater attention should be paid to the middle-aged and elderly population, especially the female population, who bear a heavier disease burden. Targeted interventions, such as weight control and smoking cessation management, should be actively implemented against these controllable risk factors.

目的:分析1990 - 2023年中国人群腰痛疾病负担变化趋势及归因危险因素,预测2030年腰痛相关疾病负担。方法:基于2023年全球疾病负担(GBD)研究数据库,分析1990 - 2023年中国腰痛患者的发病率、患病率、残疾生活年限(YLDs)、危险因素特征及趋势,评估疾病负担的年龄和性别差异,采用自回归综合移动平均模型和年龄-时期-队列模型联合预测2030年的疾病负担。结果:1990 - 2023年,中国腰痛人群的发病例数、流行例数和死亡人数均呈上升趋势,分别从2998.91万例、6863.36万例和773.24万例/年上升至4138.3万例、9532.4万例和1063.59万例/年。发病率、患病率和YLDs分别从2 543.31 / 10万、5 820.89 / 10万和655.77 / 10万增加到2 892.65 / 10万、6 663.01 / 10万和743.43 / 10万。年龄标准化发病率、年龄标准化患病率和年龄标准化YLDs呈下降趋势,分别由2 859.73 / 10万、6 636.60 / 10万和740.83 / 10万降至2 164.80 / 10万、4 929.78 / 10万和551.92 / 10万。女性腰痛负担明显高于男性,且随年龄增长而增加(50 - 59岁为高峰)。归因分析显示,吸烟、职业因素和高体质指数(BMI)是导致YLDs增加的主要因素,且存在性别差异。该模型显示,从2023年到2030年,腰痛的年龄标准化发病率、年龄标准化患病率和年龄标准化YLDs率将逐年下降。结论:中国腰痛疾病负担显示,从1990年到2023年,中国人群腰痛负担呈逐年增加趋势。吸烟、职业因素和高BMI是主要的危险因素。针对这些可控风险因素的干预措施对于减轻疾病负担至关重要。预计到2030年,腰痛的疾病负担有望减少,尽管绝对负担仍将很高。对疾病负担较重的中老年人群,特别是女性人群应给予更多的关注。针对这些可控的危险因素,应积极实施有针对性的干预措施,如体重控制和戒烟管理。
{"title":"[Analysis of disease burden, attributable risk factors of low back pain in China from 1990 to 2023 and prediction for 2030].","authors":"Jun Wei, Rundong Chai, Beier Luo, Guanyi Wang, Tianhao Yang, Xin Wang, Yiwen Yan, Ming Yan, Zhengxu Ye, Jinghui Huang, Bo Gao, Zhuojing Luo","doi":"10.7507/1002-1892.202601044","DOIUrl":"10.7507/1002-1892.202601044","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the changing trends and attributable risk factors of low back pain disease burden in Chinese population from 1990 to 2023, and to predict the related disease burden of low back pain in 2030.</p><p><strong>Methods: </strong>Based on the 2023 Global Burden of Disease (GBD) study database, the incidence, prevalence, years lived with disability (YLDs), and characteristics and trends of risk factors among Chinese individuals with low back pain from 1990 to 2023 were analyzed, the age and gender differences in disease burden were assessed, and the disease burden in 2030 was jointly predicted by autoregressive integrated moving average model and age-period-cohort model.</p><p><strong>Results: </strong>From 1990 to 2023, the number of incident cases, the number of prevalent cases, and YLDs in Chinese low back pain population showed an upward trend, from 29.989 1 million cases, 68.636 3 million cases, and 7.732 4 million person-years to 41.383 6 million cases, 95.324 0 million cases, and 10.635 9 million person-years, respectively. The incidence rate, prevalence rate, and YLDs rate increased from 2 543.31 per 100 000, 5 820.89 per 100 000, and 655.77 per 100 000 to 2 892.65 per 100 000, 6 663.01 per 100 000, and 743.43 per 100 000 respectively. However, the age-standardized incidence rate, age-standardized prevalence rate, and age-standardized YLDs rate showed a downward trend, from 2 859.73 per 100 000, 6 636.60 per 100 000, and 740.83 per 100 000 to 2 164.80 per 100 000, 4 929.78 per 100 000, and 551.92 per 100 000, respectively. The burden of low back pain in women was significantly higher than that in men and increased with age (peak at 50 to 59 years old). Attribution analysis showed that smoking, occupational factors, and high body mass index (BMI) were the main factors leading to the increase of YLDs, and there was a gender difference. The tow model showed that the age-standardized incidence rate, the age-standardized prevalence rate, and the age-standardized YLDs rate for low back pain would decrease year by year from 2023 to 2030.</p><p><strong>Conclusion: </strong>The disease burden of low back pain in China shows that from 1990 to 2023, the burden of low back pain in the Chinese population has been increasing year by year. Smoking, occupational factors, and high BMI are the main risk factors. Interventions targeting these controllable risk factors are crucial for reducing the disease burden. It is expected that by 2030, the disease burden of low back pain is expected to decrease, although the absolute burden will remain high. Greater attention should be paid to the middle-aged and elderly population, especially the female population, who bear a heavier disease burden. Targeted interventions, such as weight control and smoking cessation management, should be actively implemented against these controllable risk factors.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"414-421"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147468988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Arthroscopic-assisted closed reduction and internal fixation with absorbable screws for Hawkins type talar neck fractures]. [关节镜辅助下可吸收螺钉闭合复位内固定治疗Hawkins型Ⅱ距颈骨折]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202507112
Zhihuan Dong, Zhenhao Cao, Haiquan Dong, Housen Jiang, Lin Shi, Yanbo Zhang, Jianmin Sun

Objective: To explore the effectiveness of arthroscopic-assisted closed reduction and internal fixation with absorbable screws in the treatment of Hawkins type Ⅱ talar neck fractures.

Methods: A retrospective analysis was conducted on the clinical data of 31 patients with closed Hawkins type Ⅱ talar neck fractures between October 2021 and July 2023, all of whom were treated with arthroscopic-assisted closed reduction and internal fixation with absorbable screws. There were 18 males and 13 females with an average age of 35.9 years (range, 17-61 years). Causes of injury included sports injuries in 26 cases and impact injuries in 5 cases. The time from fracture to operation was 3-5 days (mean, 3.7 days). During follow-up, ankle pain and function were assessed using the visual analogue scale (VAS) score and the American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Score (AOFAS-AHS), while radiological examinations were used to evaluate the quality of fracture reduction and healing.

Results: All operations were successfully completed, and all incisions healed by first intention. All patients were followed up 12-16 months (mean, 13.0 months). One patient experienced persistent pain, limping, and joint dysfunction postoperatively, which returned to normal after symptomatic treatment. At 3 months after operation and last follow-up, the VAS scores were 2.7±0.9 and 1.3±0.8, respectively; the AOFAS-AHS were 74.5±4.7 and 90.9±3.6, respectively. There were significant differences in VAS score and AOFAS-AHS between different time points ( P<0.05). At last follow-up, all fractures healed, and the internal fixation was secure. No complication such as talar necrosis, subtalar joint stiffness, wound infection, or screw irritation occurred during follow-up.

Conclusion: Arthroscopic-assisted closed reduction and internal fixation with absorbable screws for Hawkins type Ⅱ talar neck fractures has the advantages of minimal trauma, precise screw placement, few complications, and avoiding secondary screw removal, with satisfactory effectiveness.

目的:探讨关节镜辅助下可吸收螺钉闭合复位内固定治疗Hawkins型Ⅱ距颈骨折的疗效。方法:回顾性分析2021年10月至2023年7月31例闭合性Hawkins型Ⅱ距颈骨折患者的临床资料,所有患者均行关节镜辅助闭合性复位及可吸收螺钉内固定。男性18例,女性13例,平均年龄35.9岁,年龄范围17 ~ 61岁。损伤原因包括运动损伤26例,撞击损伤5例。骨折至手术时间3 ~ 5天,平均3.7天。随访期间,采用视觉模拟评分(VAS)评分和美国骨科足踝学会踝关节-后足评分(AOFAS-AHS)评估踝关节疼痛和功能,同时采用影像学检查评估骨折复位和愈合质量。结果:所有手术均顺利完成,切口一期愈合。所有患者随访12-16个月(平均13.0个月)。1例患者术后出现持续疼痛、跛行和关节功能障碍,经对症治疗后恢复正常。术后3个月及末次随访时,VAS评分分别为2.7±0.9和1.3±0.8;AOFAS-AHS分别为74.5±4.7和90.9±3.6。结论:关节镜辅助下可吸收螺钉闭合复位内固定治疗Hawkins型Ⅱ距颈骨折创伤小,螺钉放置精确,并发症少,避免二次取钉,疗效满意。
{"title":"[Arthroscopic-assisted closed reduction and internal fixation with absorbable screws for Hawkins type <b>Ⅱ</b> talar neck fractures].","authors":"Zhihuan Dong, Zhenhao Cao, Haiquan Dong, Housen Jiang, Lin Shi, Yanbo Zhang, Jianmin Sun","doi":"10.7507/1002-1892.202507112","DOIUrl":"10.7507/1002-1892.202507112","url":null,"abstract":"<p><strong>Objective: </strong>To explore the effectiveness of arthroscopic-assisted closed reduction and internal fixation with absorbable screws in the treatment of Hawkins type Ⅱ talar neck fractures.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the clinical data of 31 patients with closed Hawkins type Ⅱ talar neck fractures between October 2021 and July 2023, all of whom were treated with arthroscopic-assisted closed reduction and internal fixation with absorbable screws. There were 18 males and 13 females with an average age of 35.9 years (range, 17-61 years). Causes of injury included sports injuries in 26 cases and impact injuries in 5 cases. The time from fracture to operation was 3-5 days (mean, 3.7 days). During follow-up, ankle pain and function were assessed using the visual analogue scale (VAS) score and the American Orthopaedic Foot & Ankle Society Ankle-Hindfoot Score (AOFAS-AHS), while radiological examinations were used to evaluate the quality of fracture reduction and healing.</p><p><strong>Results: </strong>All operations were successfully completed, and all incisions healed by first intention. All patients were followed up 12-16 months (mean, 13.0 months). One patient experienced persistent pain, limping, and joint dysfunction postoperatively, which returned to normal after symptomatic treatment. At 3 months after operation and last follow-up, the VAS scores were 2.7±0.9 and 1.3±0.8, respectively; the AOFAS-AHS were 74.5±4.7 and 90.9±3.6, respectively. There were significant differences in VAS score and AOFAS-AHS between different time points ( <i>P</i><0.05). At last follow-up, all fractures healed, and the internal fixation was secure. No complication such as talar necrosis, subtalar joint stiffness, wound infection, or screw irritation occurred during follow-up.</p><p><strong>Conclusion: </strong>Arthroscopic-assisted closed reduction and internal fixation with absorbable screws for Hawkins type Ⅱ talar neck fractures has the advantages of minimal trauma, precise screw placement, few complications, and avoiding secondary screw removal, with satisfactory effectiveness.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"455-459"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991880/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current status and Joinpoint regression analysis of the burden of musculoskeletal diseases in China from 1990 to 2023]. [1990 - 2023年中国肌肉骨骼疾病负担现状及关节点回归分析]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601048
Yunan Hu, Lin Hu, Qingsong Liu, Qianjiang Xiong, Jian Li, Chunxia Yang, Weili Fu

Objective: To analyze the current status and trends in the burden of musculoskeletal diseases in China from 1990 to 2023, providing evidence-based support for formulating and optimizing prevention and control strategies for musculoskeletal diseases in China.

Methods: Based on the 2023 Global Burden of Disease (GBD) study database, the study integrated incidence, prevalence, disability-adjusted life years (DALYs), and age-standardized rates of musculoskeletal diseases in the Chinese population from 1990 to 2023, stratified by gender and age. The proportional contribution to all-cause prevalence was calculated, and regression models were constructed using Joinpoint software to assess temporal trends.

Results: In 2023, the five major musculoskeletal diseases collectively accounted for approximately 25.0% of all-cause prevalence in China. Among these, osteoarthritis contributed the most (11.68%), followed by low back pain (6.89%) and neck pain (3.52%). Gout (1.28%) and rheumatoid arthritis (0.36%) had relatively lower contributions. From 1990 to 2023, the overall burden of the five major musculoskeletal diseases remained substantial, with heterogeneous temporal patterns across diseases. Stratified by age and gender, the five diseases exhibited low levels during childhood and adolescence, increased significantly in middle and older adulthood, and peaked in the elderly. Except for gout, the burden of the other four diseases was higher in females than in males across most age groups. The scale of each disease varied considerably. Osteoarthritis showed the most significant increase in prevalence, with prevalent cases increasing from 53.7668 million to 161.7424 million, and the age-standardized DALYs rate rising by 16.19%. Gout showed the fastest growth in disease burden, with age-standardized DALYs rates rising from 19.88/100 000 to 25.14/100 000 (a 26.46% increase). Although low back pain showed a decline, it remained a major source of disability over the long term, with the age-standardized DALYs rate decreasing from 740.83/100 000 to 551.92/100 000 (a 25.49% decrease). Neck pain remained generally stable with a age-standardized DALYs rate increase of 1.18%. The age-standardized incidence rate of rheumatoid arthritis increased by 19.41%, and the age-standardized DALYs rate decreased by 8.38%.

Conclusion: Over the past 30 years, the burden of musculoskeletal diseases in China has shown a persistent upward trend with significant gender and age disparities. Future prevention and control strategies should place greater emphasis on early identification and proactive interventions, advocating for more targeted comprehensive measures for high-risk populations. Concurrently, efforts must be made to enhance standardized diagnosis and treatment capabilities at the primary care level, alongside strengthening continuous rehabilitation management.

目的:分析1990 - 2023年中国肌肉骨骼疾病负担现状及趋势,为制定和优化中国肌肉骨骼疾病防控策略提供循证支持。方法:基于2023年全球疾病负担(GBD)研究数据库,综合1990年至2023年中国人群中肌肉骨骼疾病的发病率、患病率、残疾调整生命年(DALYs)和年龄标准化率,按性别和年龄分层。计算全因患病率的比例贡献,并使用Joinpoint软件构建回归模型以评估时间趋势。结果:2023年,中国五大肌肉骨骼疾病合计约占全因患病率的25.0%。其中,骨关节炎占比最大(11.68%),其次是腰痛(6.89%)和颈痛(3.52%)。痛风(1.28%)和类风湿关节炎(0.36%)的贡献相对较低。从1990年到2023年,五种主要肌肉骨骼疾病的总体负担仍然很大,不同疾病的时间模式不同。从年龄和性别上看,5种疾病在儿童期和青少年期发病率较低,在中老年期发病率显著上升,在老年期发病率最高。除痛风外,其他四种疾病的负担在大多数年龄组中女性都高于男性。每种疾病的程度差别很大。骨关节炎患病率上升最为显著,从5376.68万例增加到16174.24万例,年龄标准化DALYs率上升16.19%。痛风疾病负担增长最快,年龄标准化DALYs率从19.88/10万上升至25.14/10万(上升26.46%)。虽然腰痛有所下降,但它仍然是长期残疾的主要原因,年龄标准化DALYs率从740.83/10万下降到551.92/10万(下降25.49%)。颈部疼痛总体保持稳定,年龄标准化DALYs率增加1.18%。类风湿关节炎年龄标准化发病率上升19.41%,年龄标准化DALYs率下降8.38%。结论:近30年来,中国肌肉骨骼疾病负担呈持续上升趋势,且存在明显的性别和年龄差异。未来的预防和控制战略应更加强调早期识别和主动干预,倡导对高危人群采取更有针对性的综合措施。同时,必须努力提高初级保健一级的标准化诊断和治疗能力,同时加强持续康复管理。
{"title":"[Current status and Joinpoint regression analysis of the burden of musculoskeletal diseases in China from 1990 to 2023].","authors":"Yunan Hu, Lin Hu, Qingsong Liu, Qianjiang Xiong, Jian Li, Chunxia Yang, Weili Fu","doi":"10.7507/1002-1892.202601048","DOIUrl":"10.7507/1002-1892.202601048","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the current status and trends in the burden of musculoskeletal diseases in China from 1990 to 2023, providing evidence-based support for formulating and optimizing prevention and control strategies for musculoskeletal diseases in China.</p><p><strong>Methods: </strong>Based on the 2023 Global Burden of Disease (GBD) study database, the study integrated incidence, prevalence, disability-adjusted life years (DALYs), and age-standardized rates of musculoskeletal diseases in the Chinese population from 1990 to 2023, stratified by gender and age. The proportional contribution to all-cause prevalence was calculated, and regression models were constructed using Joinpoint software to assess temporal trends.</p><p><strong>Results: </strong>In 2023, the five major musculoskeletal diseases collectively accounted for approximately 25.0% of all-cause prevalence in China. Among these, osteoarthritis contributed the most (11.68%), followed by low back pain (6.89%) and neck pain (3.52%). Gout (1.28%) and rheumatoid arthritis (0.36%) had relatively lower contributions. From 1990 to 2023, the overall burden of the five major musculoskeletal diseases remained substantial, with heterogeneous temporal patterns across diseases. Stratified by age and gender, the five diseases exhibited low levels during childhood and adolescence, increased significantly in middle and older adulthood, and peaked in the elderly. Except for gout, the burden of the other four diseases was higher in females than in males across most age groups. The scale of each disease varied considerably. Osteoarthritis showed the most significant increase in prevalence, with prevalent cases increasing from 53.7668 million to 161.7424 million, and the age-standardized DALYs rate rising by 16.19%. Gout showed the fastest growth in disease burden, with age-standardized DALYs rates rising from 19.88/100 000 to 25.14/100 000 (a 26.46% increase). Although low back pain showed a decline, it remained a major source of disability over the long term, with the age-standardized DALYs rate decreasing from 740.83/100 000 to 551.92/100 000 (a 25.49% decrease). Neck pain remained generally stable with a age-standardized DALYs rate increase of 1.18%. The age-standardized incidence rate of rheumatoid arthritis increased by 19.41%, and the age-standardized DALYs rate decreased by 8.38%.</p><p><strong>Conclusion: </strong>Over the past 30 years, the burden of musculoskeletal diseases in China has shown a persistent upward trend with significant gender and age disparities. Future prevention and control strategies should place greater emphasis on early identification and proactive interventions, advocating for more targeted comprehensive measures for high-risk populations. Concurrently, efforts must be made to enhance standardized diagnosis and treatment capabilities at the primary care level, alongside strengthening continuous rehabilitation management.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"387-396"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of effectiveness between two endoscopic lumbar interbody fusion techniques and minimally invasive transforaminal lumbar interbody fusion for single-level lumbar degenerative disease]. [两种内镜下腰椎椎间融合术与微创经椎间孔腰椎椎间融合术治疗单节段腰椎退行性疾病的疗效比较]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202512031
Yiming Li, Weiqing Kong, Jie Li, Chao Ma, Yongxin Ren
<p><strong>Objective: </strong>To compare the effectiveness of uniportal endoscopic transforaminal lumbar interbody fusion (Endo-TLIF), unilateral biportal endoscopic transforaminal lumbar interbody fusion (UBE-TLIF), and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of single-level lumbar degenerative disease.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 130 patients with single-level lumbar degenerative disease treated between January 2019 and December 2022. According to the surgical technique, patients were divided into the MIS-TLIF group (43 cases), the Endo-TLIF group (45 cases), and the UBE-TLIF group (42 cases). Baseline data, including age, gender, operated level, disease type, preoperative lower-extremity pain visual analogue scale (VAS) score, and Oswestry disability index (ODI), showed no significant difference among the three groups ( <i>P</i>>0.05). Operation time, estimated intraoperative blood loss, postoperative hospital stays, and perioperative complications were recorded. Clinical symptoms were evaluated preoperatively and at 1 day, 1 month, 3 months, 1 year, and 2 years postoperatively using the lower-extremity pain VAS score and ODI. Interbody fusion was evaluated using the Suk method at 2 years postoperatively. Surgical outcomes and quality of life were assessed using the modified MacNab criteria and EuroQol-5 Dimensions (EQ-5D) at last follow-up.</p><p><strong>Results: </strong>There was no significant difference in operation time among the three groups ( <i>P</i>>0.05). The estimated intraoperative blood loss in MIS-TLIF group was the most, while that in Endo-TLIF group was the least, and there were significant differences among the three groups ( <i>P</i><0.05). The postoperative hospital stay was significantly shorter in the Endo-TLIF group and the UBE-TLIF group than in the MIS-TLIF group ( <i>P</i><0.05), while no significant difference was observed between the Endo-TLIF and UBE-TLIF groups ( <i>P</i>>0.05). No serious complications, such as severe neurological injury or intervertebral space infection, occurred intraoperatively in any of the three groups. In the MIS-TLIF, Endo-TLIF, and UBE-TLIF groups, some patients experienced transient neurological dysfunction, minor dural tears, or delayed wound healing, respectively; however, there was no significant difference in the overall complication incidence among the three groups (9.30% <i>vs</i> 6.67% <i>vs</i> 7.14%, <i>P</i>>0.05). All patients in the three groups were followed up 24-36 months, with an average of 26.62 months. At all postoperative follow-up time points, both lower-extremity pain VAS scores and ODI in three groups significantly improved compared to the preoperative values ( <i>P</i><0.05). In intergroup comparisons, except that the VAS score at 1 day postoperatively in the Endo-TLIF group was significantly lower than that in the MIS-TLIF group ( <i>P</i><0.05), no significant difference
目的:比较单门静脉内镜下经椎间孔腰椎体间融合术(endot - tlif)、单侧双门静脉内镜下经椎间孔腰椎体间融合术(UBE-TLIF)和微创经椎间孔腰椎体间融合术(MIS-TLIF)治疗单节段腰椎退行性疾病的疗效。方法:对2019年1月至2022年12月收治的130例单节段腰椎退行性疾病患者进行回顾性分析。根据手术技术将患者分为MIS-TLIF组(43例)、Endo-TLIF组(45例)和UBE-TLIF组(42例)。基线数据包括年龄、性别、手术程度、疾病类型、术前下肢疼痛视觉模拟评分(VAS)、Oswestry残疾指数(ODI),三组间差异均无统计学意义(P < 0.05)。记录手术时间、术中预估出血量、术后住院时间和围手术期并发症。术前及术后1天、1个月、3个月、1年、2年采用下肢疼痛VAS评分和ODI评价临床症状。术后2年采用Suk方法评估椎间融合。最后随访时采用改良的MacNab标准和EuroQol-5量表(EQ-5D)评估手术结果和生活质量。结果:三组手术时间比较,差异无统计学意义(P < 0.05)。MIS-TLIF组术中出血量最大,Endo-TLIF组术中出血量最少,三组间差异有统计学意义(PPP 0.05)。三组患者术中均未发生严重并发症,如严重神经损伤或椎间隙感染。在MIS-TLIF组、Endo-TLIF组和UBE-TLIF组中,一些患者分别出现了短暂性神经功能障碍、轻度硬脑膜撕裂或伤口愈合延迟;三组患者总并发症发生率比较,差异无统计学意义(9.30% vs 6.67% vs 7.14%, P < 0.05)。三组患者均随访24 ~ 36个月,平均26.62个月。术后各随访时间点,三组患者下肢疼痛VAS评分和ODI均较术前显著改善(PPP>0.05)。术后2年,三组患者体间固体融合率均超过92%,末次随访改良MacNab标准评定优良率均大于90%。三组患者体间融合状态、手术结果分级、EQ-5D评分差异无统计学意义(P < 0.05)。结论:Endo-TLIF和UBE-TLIF治疗单节段腰椎退行性疾病的疗效和融合率与MIS-TLIF相当,具有创伤小、出血量少、恢复快的优点。
{"title":"[Comparison of effectiveness between two endoscopic lumbar interbody fusion techniques and minimally invasive transforaminal lumbar interbody fusion for single-level lumbar degenerative disease].","authors":"Yiming Li, Weiqing Kong, Jie Li, Chao Ma, Yongxin Ren","doi":"10.7507/1002-1892.202512031","DOIUrl":"10.7507/1002-1892.202512031","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To compare the effectiveness of uniportal endoscopic transforaminal lumbar interbody fusion (Endo-TLIF), unilateral biportal endoscopic transforaminal lumbar interbody fusion (UBE-TLIF), and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in the treatment of single-level lumbar degenerative disease.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective analysis was conducted on 130 patients with single-level lumbar degenerative disease treated between January 2019 and December 2022. According to the surgical technique, patients were divided into the MIS-TLIF group (43 cases), the Endo-TLIF group (45 cases), and the UBE-TLIF group (42 cases). Baseline data, including age, gender, operated level, disease type, preoperative lower-extremity pain visual analogue scale (VAS) score, and Oswestry disability index (ODI), showed no significant difference among the three groups ( &lt;i&gt;P&lt;/i&gt;&gt;0.05). Operation time, estimated intraoperative blood loss, postoperative hospital stays, and perioperative complications were recorded. Clinical symptoms were evaluated preoperatively and at 1 day, 1 month, 3 months, 1 year, and 2 years postoperatively using the lower-extremity pain VAS score and ODI. Interbody fusion was evaluated using the Suk method at 2 years postoperatively. Surgical outcomes and quality of life were assessed using the modified MacNab criteria and EuroQol-5 Dimensions (EQ-5D) at last follow-up.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;There was no significant difference in operation time among the three groups ( &lt;i&gt;P&lt;/i&gt;&gt;0.05). The estimated intraoperative blood loss in MIS-TLIF group was the most, while that in Endo-TLIF group was the least, and there were significant differences among the three groups ( &lt;i&gt;P&lt;/i&gt;&lt;0.05). The postoperative hospital stay was significantly shorter in the Endo-TLIF group and the UBE-TLIF group than in the MIS-TLIF group ( &lt;i&gt;P&lt;/i&gt;&lt;0.05), while no significant difference was observed between the Endo-TLIF and UBE-TLIF groups ( &lt;i&gt;P&lt;/i&gt;&gt;0.05). No serious complications, such as severe neurological injury or intervertebral space infection, occurred intraoperatively in any of the three groups. In the MIS-TLIF, Endo-TLIF, and UBE-TLIF groups, some patients experienced transient neurological dysfunction, minor dural tears, or delayed wound healing, respectively; however, there was no significant difference in the overall complication incidence among the three groups (9.30% &lt;i&gt;vs&lt;/i&gt; 6.67% &lt;i&gt;vs&lt;/i&gt; 7.14%, &lt;i&gt;P&lt;/i&gt;&gt;0.05). All patients in the three groups were followed up 24-36 months, with an average of 26.62 months. At all postoperative follow-up time points, both lower-extremity pain VAS scores and ODI in three groups significantly improved compared to the preoperative values ( &lt;i&gt;P&lt;/i&gt;&lt;0.05). In intergroup comparisons, except that the VAS score at 1 day postoperatively in the Endo-TLIF group was significantly lower than that in the MIS-TLIF group ( &lt;i&gt;P&lt;/i&gt;&lt;0.05), no significant difference ","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"438-446"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficacy analysis of electrochemical detection of leukocyte esterase based on glucosyl ester in diagnosis of periprosthetic joint infection after knee arthroplasty in rabbits]. [基于葡萄糖基酯的白细胞酯酶电化学检测在兔膝关节置换术后假体周围感染诊断中的疗效分析]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202601122
Naijia Luo, Quan Chen, Tianyu Zeng, Hao Zuo, Dawen Niu, Bin Shen
<p><strong>Objective: </strong>To explore the diagnostic efficacy of electrochemical detection of synovial fluid leukocyte esterase (LE) based on glucosyl ester for periprosthetic joint infection (PJI) in rabbits.</p><p><strong>Methods: </strong>The enzyme kinetic parameters of the LE-catalyzed reaction based on glucosyl esters were determined electrochemically, and the charge-LE concentration relationship was plotted. Forty-eight healthy New Zealand rabbits were randomly divided into a sham-operation group (blank group), a knee joint metal prosthesis implantation group (control group), and a knee joint metal prosthesis implantation with PJI group (experimental group), with 16 rabbits in each group. The experimental group underwent intra-articular injection of 1×10 <sup>5</sup> CFU/mL <i>Staphylococcus aureus</i> suspension at 7 days after right knee joint prosthesis implantation. The control group underwent intra-articular injection of 1 mL of sterile saline at 7 days after right knee joint prosthesis implantation. The blank group underwent right knee joint capsule incision and suture, followed by intra-articular injection of 1 mL of sterile saline 7 days later. The general condition of the animals was observed after operation. At 28 days after operation, imaging examination, microbiological examination, hematological test, and electrochemical detection of synovial fluid LE were performed. The area (AUC) under the receiver operating characteristic curve (ROC) was used to evaluate the sensitivity and specificity of LE-based detection of PJI.</p><p><strong>Results: </strong>The Michaelis constant of the enzymatic reaction of LE catalyzing glucosyl ester was 7.335 mmol/L, and the maximum reaction rate of the enzymatic reaction was 63.750 μmol·L <sup>-1</sup>·min <sup>-1</sup>. The calibration curve regression equation for the charge difference (ΔQ)-LE concentration was C <sub>(LE)</sub>=0.7115ΔQ-14.75, with a determination coefficient <i>R</i> <sup>2</sup> of 0.988 4 (95% <i>CI</i>: 0.5698, 0.8532, <i>P</i><0.001). All animals survived to the end of the experiment. During the period, the experimental group showed signs of joint infection, and the microbiological test results were all positive. The other two groups had no related infection manifestations and the tests were negative. Imaging examination showed that the experimental prosthesis was stable in position, soft tissue swelling around the joint and mild deformation in the joint. There was no obvious swelling in the soft tissue around the joints in the other two groups, and the joints were in good alignment. Synovial fluid and hematological tests revealed that the experimental group exhibited significantly higher levels of LE, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell count (WBC), neutrophil count (Neu), and monocytes count (Mon) compared to both the control group and the blank group ( <i>P</i><0.05). Notably, ESR and Mon levels were significantly higher
目的:探讨葡萄糖基酯电化学检测滑膜液白细胞酯酶(LE)对兔假体周围关节感染(PJI)的诊断价值。方法:采用电化学方法测定葡萄糖基酯催化le反应的酶动力学参数,并绘制电荷- le浓度关系图。选取健康新西兰兔48只,随机分为假手术组(空白组)、膝关节金属假体植入组(对照组)和膝关节金属假体植入PJI组(实验组),每组16只。实验组患者于右膝关节假体植入后第7天关节内注射1×10 5 CFU/mL金黄色葡萄球菌悬液。对照组患者于右膝关节假体植入后第7天关节内注射无菌生理盐水1 mL。空白组右膝关节囊切开缝合,7 d后关节内注射无菌生理盐水1 mL。术后观察动物一般情况。术后28 d行影像学检查、微生物学检查、血液学检查、电化学检测滑液LE。采用受试者工作特征曲线(ROC)下面积(AUC)评价基于le检测PJI的敏感性和特异性。结果:LE催化葡萄糖基酯酶促反应的米氏常数为7.335 mmol/L,酶促反应的最大反应速率为63.750 μmol·L -1·min -1。电荷差(ΔQ)-LE浓度的校正曲线回归方程为C (LE)=0.7115ΔQ-14.75,决定系数r2为0.988 4 (95% CI: 0.5698, 0.8532, PPP0.9 (p))结论:滑液LE和血液学检测对兔PJI模型均有较好的诊断效果,基于葡萄糖基酯电化学定量检测LE的方法具有较高的特异性、敏感性和准确性。
{"title":"[Efficacy analysis of electrochemical detection of leukocyte esterase based on glucosyl ester in diagnosis of periprosthetic joint infection after knee arthroplasty in rabbits].","authors":"Naijia Luo, Quan Chen, Tianyu Zeng, Hao Zuo, Dawen Niu, Bin Shen","doi":"10.7507/1002-1892.202601122","DOIUrl":"10.7507/1002-1892.202601122","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To explore the diagnostic efficacy of electrochemical detection of synovial fluid leukocyte esterase (LE) based on glucosyl ester for periprosthetic joint infection (PJI) in rabbits.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The enzyme kinetic parameters of the LE-catalyzed reaction based on glucosyl esters were determined electrochemically, and the charge-LE concentration relationship was plotted. Forty-eight healthy New Zealand rabbits were randomly divided into a sham-operation group (blank group), a knee joint metal prosthesis implantation group (control group), and a knee joint metal prosthesis implantation with PJI group (experimental group), with 16 rabbits in each group. The experimental group underwent intra-articular injection of 1×10 &lt;sup&gt;5&lt;/sup&gt; CFU/mL &lt;i&gt;Staphylococcus aureus&lt;/i&gt; suspension at 7 days after right knee joint prosthesis implantation. The control group underwent intra-articular injection of 1 mL of sterile saline at 7 days after right knee joint prosthesis implantation. The blank group underwent right knee joint capsule incision and suture, followed by intra-articular injection of 1 mL of sterile saline 7 days later. The general condition of the animals was observed after operation. At 28 days after operation, imaging examination, microbiological examination, hematological test, and electrochemical detection of synovial fluid LE were performed. The area (AUC) under the receiver operating characteristic curve (ROC) was used to evaluate the sensitivity and specificity of LE-based detection of PJI.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The Michaelis constant of the enzymatic reaction of LE catalyzing glucosyl ester was 7.335 mmol/L, and the maximum reaction rate of the enzymatic reaction was 63.750 μmol·L &lt;sup&gt;-1&lt;/sup&gt;·min &lt;sup&gt;-1&lt;/sup&gt;. The calibration curve regression equation for the charge difference (ΔQ)-LE concentration was C &lt;sub&gt;(LE)&lt;/sub&gt;=0.7115ΔQ-14.75, with a determination coefficient &lt;i&gt;R&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt; of 0.988 4 (95% &lt;i&gt;CI&lt;/i&gt;: 0.5698, 0.8532, &lt;i&gt;P&lt;/i&gt;&lt;0.001). All animals survived to the end of the experiment. During the period, the experimental group showed signs of joint infection, and the microbiological test results were all positive. The other two groups had no related infection manifestations and the tests were negative. Imaging examination showed that the experimental prosthesis was stable in position, soft tissue swelling around the joint and mild deformation in the joint. There was no obvious swelling in the soft tissue around the joints in the other two groups, and the joints were in good alignment. Synovial fluid and hematological tests revealed that the experimental group exhibited significantly higher levels of LE, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell count (WBC), neutrophil count (Neu), and monocytes count (Mon) compared to both the control group and the blank group ( &lt;i&gt;P&lt;/i&gt;&lt;0.05). Notably, ESR and Mon levels were significantly higher","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"460-468"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progress in diagnosis and treatment of finger flexion deformity caused by forearm flexor muscle lesions]. [前臂屈肌病变致手指屈曲畸形的诊治进展]。
Q3 Medicine Pub Date : 2026-03-15 DOI: 10.7507/1002-1892.202511014
Yingliang Jiang, Jianwei Wei

Objective: To summarize the current research progress of finger flexion deformity caused by forearm flexor muscle lesions, providing a reference for clinical diagnosis and treatment.

Methods: The domestic and international literature about finger flexion deformity caused by forearm flexor muscle lesions was extensively reviewed. A summary analysis was conducted from the etiology and pathogenesis, diagnosis and differential diagnosis, and treatment methods.

Results: The three types of forearm flexor pathology leading to finger flexion deformity include Volkmann's contracture, pseudo-Volkmann's contracture, and congenital flexor muscle lesions with different pathogenesis. The diagnosis is mainly based on the patient's medical history, clinical features, and imaging examinations, with attention paid to differential diagnosis. Currently, conservative treatment for such deformities is not very effective, and surgical treatment is mainly adopted. According to the causes and severity, options such as resection of the contracture band, resection of contracture band, release of compressed muscle (tendon), and flexor origin muscle sliding surgery, could be performed to correct hand deformities and restore hand function, and thus resulting in favorable outcomes.

Conclusion: Volkmann's contracture, pseudo-Volkmann's contracture, and congenital flexor muscle lesions causing finger flexion deformity have different causes and pathogenesis, which can be distinguished by carefully inquiring about the medical history, the clinical characteristics of the three, and imaging examinations, thereby selecting appropriate treatment methods.

目的:总结目前前臂屈肌病变所致手指屈曲畸形的研究进展,为临床诊断和治疗提供参考。方法:广泛查阅国内外有关前臂屈肌病变导致手指屈曲畸形的文献。从病因病机、诊断与鉴别诊断、治疗方法等方面进行总结分析。结果:导致手指屈曲畸形的前臂屈肌病理类型包括Volkmann挛缩症、假性Volkmann挛缩症和先天性屈肌病变,其发病机制不同。诊断主要根据患者的病史、临床特征和影像学检查,注意鉴别诊断。目前对于此类畸形的保守治疗效果不佳,主要采用手术治疗。根据原因和严重程度,可采取挛缩带切除术、挛缩带切除术、压迫肌(肌腱)松解、屈肌起始肌滑动手术等方法矫正手部畸形,恢复手部功能,效果良好。结论:Volkmann挛缩症、假性Volkmann挛缩症和先天性屈曲肌病变引起的手指屈曲畸形有不同的病因和发病机制,可通过仔细询问病史、三者的临床特点和影像学检查来鉴别,从而选择合适的治疗方法。
{"title":"[Progress in diagnosis and treatment of finger flexion deformity caused by forearm flexor muscle lesions].","authors":"Yingliang Jiang, Jianwei Wei","doi":"10.7507/1002-1892.202511014","DOIUrl":"10.7507/1002-1892.202511014","url":null,"abstract":"<p><strong>Objective: </strong>To summarize the current research progress of finger flexion deformity caused by forearm flexor muscle lesions, providing a reference for clinical diagnosis and treatment.</p><p><strong>Methods: </strong>The domestic and international literature about finger flexion deformity caused by forearm flexor muscle lesions was extensively reviewed. A summary analysis was conducted from the etiology and pathogenesis, diagnosis and differential diagnosis, and treatment methods.</p><p><strong>Results: </strong>The three types of forearm flexor pathology leading to finger flexion deformity include Volkmann's contracture, pseudo-Volkmann's contracture, and congenital flexor muscle lesions with different pathogenesis. The diagnosis is mainly based on the patient's medical history, clinical features, and imaging examinations, with attention paid to differential diagnosis. Currently, conservative treatment for such deformities is not very effective, and surgical treatment is mainly adopted. According to the causes and severity, options such as resection of the contracture band, resection of contracture band, release of compressed muscle (tendon), and flexor origin muscle sliding surgery, could be performed to correct hand deformities and restore hand function, and thus resulting in favorable outcomes.</p><p><strong>Conclusion: </strong>Volkmann's contracture, pseudo-Volkmann's contracture, and congenital flexor muscle lesions causing finger flexion deformity have different causes and pathogenesis, which can be distinguished by carefully inquiring about the medical history, the clinical characteristics of the three, and imaging examinations, thereby selecting appropriate treatment methods.</p>","PeriodicalId":23979,"journal":{"name":"中国修复重建外科杂志","volume":"40 3","pages":"469-475"},"PeriodicalIF":0.0,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12991879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147469307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国修复重建外科杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1